Invest1 distinct publisher3 min readPublished
The Section 1260H label leaves American firms free to buy CXMT chips, so what the lawsuit really contests is the political cost to customers like Apple, at a moment when the big three hold 90% of DRAM revenue.
The Investor · Invest desk

Compiled by The InvestorSomething wrong?How this is made
Take Quartz's figures at face value and the net margin on CXMT's first half is 51.6% [1], which is an awkward number for the tidiest version of the company's own story. Run the growth rate backwards and the base is tiny: revenue up 874% puts the year-earlier half near 15.4 billion yuan [2], call it $2.3 billion at the exchange rate implied by the company's own dollar translation [3]. A supplier annualising toward $44.8 billion [4] while keeping half of it as profit is collecting the shortage rent rather than dissolving it, and that is the first thing I would put to anyone arguing that letting the fourth player in would cool DRAM prices.
The bit arithmetic points the same way. The three incumbents held about 90% of Q2 2026 DRAM revenue [8], leaving at most a tenth of the industry's money for CXMT and every other minor supplier combined [5], while CXMT already moves close to 9% of global bits [10]. Dollars per bit at or below the industry average [6] is what you would expect from conventional DRAM rather than the high-bandwidth parts AI servers are queueing for, and Counterpoint's forecast is that conventional prices climb anyway, because agentic AI and server builds keep absorbing the capacity that used to make them [11].
What is being litigated, then, is a customer's political cost, or rather the transferable version of it. The Pentagon's 1260H list is not the Commerce Entity List and American companies remain free to buy CXMT chips [6]; the harder edge is the FY2023 NDAA clause barring federal agencies from using goods containing CXMT semiconductors from December 2027 [7], which reaches through any manufacturer with a government line of business. CXMT told the District Court for the District of Columbia [2] that the determinations are unsupported by the factual record and that it "is not affiliated with the Chinese military" [4], selling into civilian and commercial channels [14]; the Pentagon said it cannot comment on pending litigation [5]. Apple, meanwhile, is weighing CXMT memory [15] after AI-driven memory costs pushed some iPad and MacBook prices up by as much as 20% [16], and a bipartisan group of senators has told Apple to refuse, on the explicit theory that approval by so demanding a buyer would carry the rest of the industry with it [17].
That senatorial theory is the strongest evidence for my read, which is that the marginal DRAM bit available to Western buyers is now gated by a designation rather than by a fab. This is probably wrong in one specific way: if the binding scarcity sits in high-bandwidth memory and packaging, then admitting the only credible fourth supplier [18] relieves phones and PCs and leaves AI server pricing exactly where it was. Two other paths are open. CXMT wins the case and discovers the 2027 procurement clause still keeps regulated buyers away, making the victory reputational; or Apple qualifies it, other original equipment makers follow, and conventional contract prices flatten, which is the only outcome that would show policy was setting the price. The falsifier is cheap to check: if CXMT volume reaches Western buyers and contract prices keep rising anyway, the fourth supplier was never the constraint.
One caveat on the record. All of this arrives through a single publisher relaying Reuters on the filing [1], Counterpoint on share [8] and Quartz on the accounts [12], and a $22.4 billion half-year at a company whose bit share is under a tenth is large enough that I would want the underlying statements in hand before leaning on the margin.
Ranked by verification strength, evidence, and original report placement.
ChangXin Memory Technologies (CXMT) filed suit against the U.S. Department of Defense on Friday, seeking to overturn its designation as a "Chinese military company", according to Reuters.
CXMT filed the lawsuit in the U.S. District Court for the District of Columbia.
The lawsuit names Secretary of Defense Peter Hegseth, Deputy Secretary Steve Feinberg and Chief of Industrial Base Policy Michael Cadenazzi as defendants.
CXMT said the Pentagon's decision was arbitrary, baseless and procedurally flawed, stating "CXMT is not affiliated with the Chinese military" and that "none of these determinations is supported by the factual record, by applicable law, or by reasoned decision-making", as reported by Reuters.
The Department of Defense told Reuters it cannot comment on ongoing lawsuits or litigation in progress.
The Pentagon's Section 1260H List is not equivalent to the Commerce Department's Entity List, and U.S. companies may still purchase CXMT chips, though the military-company designation carries consequences for federal contracts.
Distinct publishers with included, body-backed reporting in this cluster.
1 article · August 29, 2026
Follow any of these and your For You feed starts watching them — no settings page required.
invest
CXMT's ceiling is 240,000 wafers a month, and that is the DRAM price forecast1 distinct publisher
build
Micron's own numbers say the DRAM squeeze is an allocation problem, not a cycle1 distinct publisher
invest
Half a book in two memory names: what Situational Awareness's 67% month actually shows1 distinct publisher
invest
Micron's $10B Boise lab admits fabs alone will not close the HBM gap1 distinct publisher
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
Relayed, never re-reported
Nothing in this story was gathered by the outlet publishing it. The complaint comes through Reuters, the share data through Counterpoint Research, the half-year financials through Quartz's read of CXMT's own results, and the Apple thread through Cryptopolitan citing an earlier Cryptopolitan piece. No docket number, no filing date beyond "Friday", no quoted document. What lifts the score above the floor is that the legally decisive point is handled correctly rather than dramatised: 1260H is not the Entity List, purchases stay legal, and the real cliff is a separate statute dated December 2027.
Real bits, no named Western buyer
Nine percent of the world's DRAM bits and a half-year profit of 77.61 billion yuan is adoption as a fact of the market, not a projection. But every American link in the chain is still hypothetical: Apple is deliberating, senators are lobbying against it, and Washington has pre-committed federal agencies to non-adoption from December 2027. Not one customer using CXMT memory today is named anywhere in this reporting.
Disciplined frame, unchecked arithmetic
The overreach is narrow but real. Calling CXMT "the only real fourth player" does load the argument with a judgment no cited data supports — no other second-tier supplier is measured here. And the figures quietly fight: annualise the reported $22.4 billion first half and drop it into the at-most-10% of revenue the big three leave over, and you need a global DRAM market of roughly $450 billion for both numbers to survive. Set against that, the piece declines the easy exaggeration: it says out loud that American firms can still buy these chips.
A plaintiff's pleading and the plaintiff's books
Follow who benefits from each pillar. "Arbitrary, baseless and procedurally flawed" is litigation language from the party seeking removal, quoted as such. The growth and margin figures come from CXMT's own results, published in the same season it is arguing before a federal court that it is an ordinary commercial memory vendor. Counterpoint sells the market data it is cited for. The Pentagon says nothing, and Apple says nothing — so every voice with something at stake in the outcome is a voice arguing one side of it.
Trust the shape, verify the size
Split the story in two and confidence splits with it. The events — suit filed, court, named defendants, two lists that are not the same list, a December 2027 deadline — are reliable enough to plan around. The magnitudes and the verdict on market structure are one publisher's assembly of other people's numbers, and the outcome that actually matters will be written on a docket nobody here has read.